Download presentation
Presentation is loading. Please wait.
Published byMyles Foster Modified over 9 years ago
1
© NuAge Vision 2014 Email: admin@nuage-vision.comadmin@nuage-vision.com Webwww.nuage-vision.com Tel:+44 (0) 7803 122 583 +44 (0) 7553 040 928 Creating and Running Companies Bruce Savage BioQuest Consulting What do I do? Work with scientific founder/university to write business plan, raise investment and run the business on part time basis I am currently on start up no 8 Have raised £14m
2
© NuAge Vision 2014 Email: admin@nuage-vision.comadmin@nuage-vision.com Webwww.nuage-vision.com Tel:+44 (0) 7803 122 583 +44 (0) 7553 040 928 Critical issues in running a successful company Credible, realistic business plan Strong focus on how co will make money and how it will give investors a good return Raising adequate investment Experienced management Strong, clean IP with a plan to increase patent portfolio
3
© NuAge Vision 2014 Email: admin@nuage-vision.comadmin@nuage-vision.com Webwww.nuage-vision.com Tel:+44 (0) 7803 122 583 +44 (0) 7553 040 928 Comments on IP Investors invest in your patents – your major asset BUT looking for quality patents in application do not have same value as granted patents A good examination report can help with investment Road to obtaining a granted patent can be long and expensive and risky A freedom to operate search can help investors confidence
4
© NuAge Vision 2014 Email: admin@nuage-vision.comadmin@nuage-vision.com Webwww.nuage-vision.com Tel:+44 (0) 7803 122 583 +44 (0) 7553 040 928 How to build real value Substantiate claims Reduce to practice Build a portfolio around core patent Demonstrate real commercial value of IP by showing strong growth in sales of patent protected products
5
© NuAge Vision 2014 Email: admin@nuage-vision.comadmin@nuage-vision.com Webwww.nuage-vision.com Tel:+44 (0) 7803 122 583 +44 (0) 7553 040 928 Cytocell Molecular diagnostics company detection of genetic diseases Sold products worldwide through distributors 98% sales outside UK Core technology – through collaboration and sought licensing deals IP problems principally in US In licensed main product from Univ Oxford
6
© NuAge Vision 2014 Email: admin@nuage-vision.comadmin@nuage-vision.com Webwww.nuage-vision.com Tel:+44 (0) 7803 122 583 +44 (0) 7553 040 928 BioAnalab Spin out from Univ Oxford – service company with pharma companies as customers Strong growth in sales through Web site Conferences Business development exec. Know-how (SOP’s) but not patents licensed from university Great deal of know-how in complex field
7
© NuAge Vision 2014 Email: admin@nuage-vision.comadmin@nuage-vision.com Webwww.nuage-vision.com Tel:+44 (0) 7803 122 583 +44 (0) 7553 040 928 CMP Therapeutics Novel treatment for allergies based on natural product IP assigned (not licensed) from Medical Research Council Commercialisation through license deals once efficacy shown in clinical trials IP issues in US but solved by inventor meeting USPO
8
© NuAge Vision 2014 Email: admin@nuage-vision.comadmin@nuage-vision.com Webwww.nuage-vision.com Tel:+44 (0) 7803 122 583 +44 (0) 7553 040 928 GFC Diagnostics Test kits to detect smoking – insurance industry and hospital customers Sales generated mainly through web site - worldwide and some personal selling Initial patent on device lapsed but new patent filed on new chemistry, granted in US with no issues!! Patent filing fees big cost Strong growth in sales
9
© NuAge Vision 2014 Email: admin@nuage-vision.comadmin@nuage-vision.com Webwww.nuage-vision.com Tel:+44 (0) 7803 122 583 +44 (0) 7553 040 928 Summary A granted patent really helps raise investment but there are other important considerations Business plan must have a focus on a realistic commercialisation plan with a credible exit strategy. Good management with experienced sales and marketing team Good luck – especially with US patent office!
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.